Skip to Content
Merck
All Photos(1)

Key Documents

More Documents

M-012

Supelco

(±)-MDA solution

1.0 mg/mL in methanol, ampule of 1 mL, certified reference material, Cerilliant®

Synonym(s):

(±)-3,4-Methylenedioxyamphetamine

Sign Into View Organizational & Contract Pricing
All Photos(1)

About This Item

Empirical Formula (Hill Notation):
C10H13NO2
CAS Number:
4764-17-4
Molecular Weight:
179.22
MDL number:
MFCD00867901
UNSPSC Code:
41116107
PubChem Substance ID:
329817726
NACRES:
NA.24

grade

certified reference material

form

liquid

feature

Snap-N-Spike®/Snap-N-Shoot®

packaging

ampule of 1 mL

manufacturer/tradename

Cerilliant®

drug control

Narcotic Licence Schedule D (Switzerland); psicótropo (Spain); Decreto Lei 15/93: Tabela IIA (Portugal)

concentration

1.0 mg/mL in methanol

technique(s)

gas chromatography (GC): suitable
liquid chromatography (LC): suitable

application(s)

forensics and toxicology

format

single component solution

storage temp.

−20°C

SMILES string

NC(C)CC1=CC=C(OCO2)C2=C1

InChI

1S/C10H13NO2/c1-7(11)4-8-2-3-9-10(5-8)13-6-12-9/h2-3,5,7H,4,6,11H2,1H3

InChI key

NGBBVGZWCFBOGO-UHFFFAOYSA-N

Related Categories

General description

A certified solution standard suitable to use in LC/MS or GC/MS applications for clinical toxicology, forensic analysis, or urine drug testing. MDA, or 3,4-methylenedioxyamphetamine, is an illicit recreational drug of the amphetamine and phenethylamine classes. Also known as tenamphetamine, MDA is abused for its psychedelic and hallucinogenic effects, similar to those of MDMA (Ecstasy).

Application

  • MDA Research Chemical: (±)-MDA solution is extensively used in scientific research to study its pharmacological properties, including its effects on neurotransmitter systems which are critical in understanding substance-related disorders.
  • MDA Enantiomers: The solution includes both enantiomers of MDA, allowing for detailed studies on the differential biological activities of each enantiomer in neuropharmacological research.
  • Synthetic MDA Solution: This synthetic solution is crucial for controlled studies in biochemistry and pharmacology, providing a consistent baseline for experimental reproducibility and validation.
  • MDA Biochemistry Application: Utilized in biochemical assays, (±)-MDA solution helps in the exploration of its metabolic pathways and interactions with biological macromolecules, enhancing the understanding of its pharmacodynamics.
  • MDA Pharmacological Studies: As a key tool in pharmacological research, (±)-MDA solution is used to investigate its potential therapeutic effects and risks, contributing to the development of safety guidelines and therapeutic protocols.

Legal Information

CERILLIANT is a registered trademark of Merck KGaA, Darmstadt, Germany
Snap-N-Shoot is a registered trademark of Cerilliant Corporation
Snap-N-Spike is a registered trademark of Merck KGaA, Darmstadt, Germany

related product

Product No.
Description
Pricing

A-050

Amine Mixture-6 solution, 250 μg/mL each component in methanol, ampule of 1 mL, certified reference material, Cerilliant®

M-010

(±)-MDA-D5 solution, 100 μg/mL in methanol, ampule of 1 mL, certified reference material, Cerilliant®

M-011

(±)-MDMA-D5 solution, 100 μg/mL in methanol, ampule of 1 mL, certified reference material, Cerilliant®

M-013

(±)-MDMA solution, 1.0 mg/mL in methanol, ampule of 1 mL, certified reference material, Cerilliant®

M-027

(±)-MDA-D5 solution, 1.0 mg/mL in methanol, ampule of 1 mL, certified reference material, Cerilliant®

M-029

(±)-MDMA-D5 solution, 1.0 mg/mL in methanol, ampule of 1 mL, certified reference material, Cerilliant®

M-065

(±)-MDEA solution, 1.0 mg/mL in methanol, ampule of 1 mL, certified reference material, Cerilliant®

M-067

(±)-MDEA-D5 solution, 100 μg/mL in methanol, ampule of 1 mL, certified reference material, Cerilliant®

M-068

(±)-MDEA-D5 solution, 1.0 mg/mL in methanol, ampule of 1 mL, certified reference material, Cerilliant®

M-081

(±)-MDEA-D6 solution, 100 μg/mL in methanol, ampule of 1 mL, certified reference material, Cerilliant®

M-082

(±)-MDEA-D6 solution, 1.0 mg/mL in methanol, ampule of 1 mL, certified reference material, Cerilliant®

M-144

MDAI hydrochloride solution, 100 μg/mL in acetonitrile: water (9:1) with 5% 1 M HCl (as free base), ampule of 1 mL, certified reference material, Cerilliant®

Signal Word

Danger

Hazard Classifications

Acute Tox. 3 Dermal - Acute Tox. 3 Inhalation - Acute Tox. 3 Oral - Flam. Liq. 2 - STOT SE 1

Target Organs

Eyes

Storage Class Code

3 - Flammable liquids

WGK

WGK 1

Flash Point(F)

49.5 °F - closed cup

Flash Point(C)

9.7 °C - closed cup

Certificates of Analysis (COA)

Search for Certificates of Analysis (COA) by entering the products Lot/Batch Number. Lot and Batch Numbers can be found on a product’s label following the words ‘Lot’ or ‘Batch’.

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

Sebastian Rojek et al.
Forensic science international, 222(1-3), e1-e6 (2012-06-01)
The easily available "legal highs", which are products containing psychoactive substances, such as cathinones, piperazines and synthetic cannabinoids, are abused by adolescents in Poland and in the world as alternatives to classic drugs, such as amphetamines or marijuana. The majority
Juan Bin et al.
Metabolic brain disease, 27(4), 495-505 (2012-07-31)
The calcium sensitizers levosimendan and piperphentonamine hydrochloride (PPTA) are used as cardiovascular drugs for treatment of heart failure. Given that levosimendan has been reported to exhibit a neuroprotective profile in a model of traumatic brain injury, it was interesting to
Aixin Shi et al.
Journal of chromatography. B, Analytical technologies in the biomedical and life sciences, 908, 87-93 (2012-11-06)
Piperphentonamine hydrochloride (PPTA) is a new calcium sensitizer. A liquid chromatography-tandem mass spectrometry (LC/MS/MS) method for determination of piperphentonamine and its metabolites M1 and M6 was developed for the first time and applied to a pharmacokinetics study. Protein precipitation was
Cédric M Hysek et al.
PloS one, 7(5), e36476-e36476 (2012-05-11)
This study assessed the effects of the serotonin (5-HT) and norepinephrine (NE) transporter inhibitor duloxetine on the effects of 3,4-methylenedioxy-methamphetamine (MDMA, ecstasy) in vitro and in 16 healthy subjects. The clinical study used a double-blind, randomized, placebo-controlled, four-session, crossover design.
M Coppola et al.
Toxicology letters, 218(1), 24-29 (2013-01-26)
In 2010, an internet snapshot of EMCDDA anticipated the presence of 5-iodo-2-aminoindan (5-IAI) within the recreational drug market. In 2011, this compound, a psychoactive derivative of 2-aminoindane, was identified in recreational products sold in the United Kingdom. 5-IAI is a
View All Related Papers

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service